ANI Pharmaceuticals Inc. (ANIP)

80.75
NASDAQ : Health Technology
Prev Close 81.00
Day Low/High 79.84 / 81.39
52 Wk Low/High 36.92 / 84.10
Avg Volume 142.10K
Exchange NASDAQ
Shares Outstanding 12.04M
Market Cap 975.88M
EPS 1.30
P/E Ratio 69.83
Div & Yield N.A. (N.A)

Latest News

3 Profitable Small Biotech Names to Consider

3 Profitable Small Biotech Names to Consider

Exelixis Inc., ANI Pharmaceuticals and Supernus Pharmaceuticals should not need to raise more capital in the foreseeable future.

Here's a Handful of Ways to Navigate Biotech's Choppy Seas

Here's a Handful of Ways to Navigate Biotech's Choppy Seas

Biotech ETFs could mitigate risk amid the sector's volatility, and names such as Exelixis, ANI Pharmaceuticals and Progenics hold promise.

Small-Caps Offer Port in Stormy Trade Seas

Small-Caps Offer Port in Stormy Trade Seas

Small-caps also should benefit from reduced corporate income taxes and strong U.S. economic growth.

Getting Ready for Biotech Earnings

Getting Ready for Biotech Earnings

Now that M&A is picking up in the sector, here's what to watch as earnings releases begin to hit.

3 Promising Biotech Stocks to Buy on Dips

3 Promising Biotech Stocks to Buy on Dips

From ANI Pharmaceuticals to T2 Biosystems, these names look good.

Three Biotech Opportunities

Three Biotech Opportunities

Celgene, ANI and T2 are seeing attractive entry points.

3 Small-Caps on My Growth Stock Radar

3 Small-Caps on My Growth Stock Radar

LGI Homes, ANI Pharmaceuticals and Sonus Networks are worth considering.

2 Small Biopharma Stocks on the Move

2 Small Biopharma Stocks on the Move

The oversold biotech sector is recovering.

Cashing In on the Biotech Bear Market

Cashing In on the Biotech Bear Market

My 4-Tier approach to deploying new capital in the sector.

Stocks Slightly Lower Amid Yellen's Rate-Hike Hints

Stocks are trading in a relatively narrow range, but are slightly down after Federal Reserve chair Janet Yellen hinted at a possible December rate hike. Still, her remarks are only having a minor impact on the market given the many Fed "head fakes" ...

Thank God It's Friday!

Good morning! Bret Jensen here. I'm happy to be filling in for Doug Kass during this last trading day of October. It's been a good month for investors after a very bumpy August and September. All the major indices are up nicely for the month, despit...

6 Biotechs I Like for Earnings Season

6 Biotechs I Like for Earnings Season

These stocks should all show solid third-quarter results.

How to Build a Good Foundation in Biotechs

How to Build a Good Foundation in Biotechs

A so-called "pyramid strategy" can help you enter the depressed sector.

Horizon and ANI Appeal in Pharma Selloff

Horizon and ANI Appeal in Pharma Selloff

Some smaller biotechs offer good value at current levels.

Biotech Investors: Ignore Hillary's Election-Inspired Silliness

Does anyone think efforts to inject more government into the private health care market will go anywhere?

Biotech, Hillary and Election Silliness

Biotech, Hillary and Election Silliness

Does anyone think efforts to inject more government into the private health care market will go anywhere?

Celgene on My Shopping List for a Pullback

Celgene on My Shopping List for a Pullback

I have about 25% in cash; if the market falls 5-10%, I'm in.

Why You Should Adopt Little Orphan ANI

Why You Should Adopt Little Orphan ANI

The sun could come out tomorrow for this small, depressed biotech.

Failed Greece Negotiations Hit Futures; Dollar Worries Persist

But investors are likely to be wary ahead of the Fed meeting.

Put Health Care Stocks on Shopping List

Put Health Care Stocks on Shopping List

Have it ready in case market turns volatile.

Nasdaq 5000 Is Meaningless

Stay focused on price and remember that the market's riding a trend.

S&P Loses Important Support

S&P Loses Important Support

The upward move that began in mid-October has become, at best, a sideways move.